Posted by Michael Wonder on 15 Nov 2018
'Death sentence': One-in-a-million rare cancers get the 'sorting hat' treatment
13 November 2018 - For people with the rarest of cancers, the hope of survival or an effective treatment can be scarcer than the diagnosis itself.
But a "cracking" new trial is redefining the odds, matching one-in-a-million patients with effective treatments already being used to treat common cancers.
The pilot phase of the Nominator trial has matched one in five patients with extremely rare "orphan" cancers to existing treatments, by genetically sequencing their cancers to identify genetic markers or mutations they share with some of the most prevalent, well-funded and highly researched cancers in Australia.
